Amedisys Cost of Goods Sold 2010-2024 | AMED

Amedisys cost of goods sold from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
Amedisys Annual Cost of Goods Sold
(Millions of US $)
2023 $1,246
2022 $1,260
2021 $1,233
2020 $1,185
2019 $1,150
2018 $993
2017 $903
2016 $834
2015 $726
2014 $691
2013 $718
2012 $811
2011 $750
2010 $794
2009 $706
Amedisys Quarterly Cost of Goods Sold
(Millions of US $)
2024-09-30 $338
2024-06-30 $327
2024-03-31 $322
2023-12-31 $321
2023-09-30 $312
2023-06-30 $297
2023-03-31 $315
2022-12-31 $317
2022-09-30 $322
2022-06-30 $316
2022-03-31 $305
2021-12-31 $317
2021-09-30 $310
2021-06-30 $309
2021-03-31 $297
2020-12-31 $307
2020-09-30 $298
2020-06-30 $295
2020-03-31 $286
2019-12-31 $296
2019-09-30 $289
2019-06-30 $291
2019-03-31 $275
2018-12-31 $262
2018-09-30 $250
2018-06-30 $243
2018-03-31 $238
2017-12-31 $239
2017-09-30 $227
2017-06-30 $221
2017-03-31 $216
2016-12-31 $214
2016-09-30 $212
2016-06-30 $207
2016-03-31 $202
2015-12-31 $192
2015-09-30 $187
2015-06-30 $176
2015-03-31 $171
2014-12-31 $171
2014-09-30 $170
2014-06-30 $173
2014-03-31 $177
2013-12-31 $179
2013-09-30 $175
2013-06-30 $178
2013-03-31 $186
2012-12-31 $193
2012-09-30 $207
2012-06-30 $203
2012-03-31 $209
2011-12-31 $172
2011-09-30 $202
2011-06-30 $189
2011-03-31 $187
2010-12-31 $174
2010-09-30 $206
2010-06-30 $209
2010-03-31 $204
2009-12-31 $179
2009-09-30 $184
2009-06-30 $178
2009-03-31 $165
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $2.744B $2.236B
Amedisys Inc. provides home health and hospice services throughout the U.S. to the growing chronic, co-morbid, and aging American population. The company also offers clinically focused programs for chronic conditions and various diseases such as diabetes, coronary artery disease, congestive heart failure, orthopedics, complex wound care, geriatric surgical recovery, balance retraining, behavioral health and stroke recovery, as well as various rehabilitative programs. It provides hospice services to patients using an interdisciplinary care team comprising a physician, nurses, home health aides, social workers, therapists, dieticians, volunteers, counselors, chaplains and bereavement coordinators, when required. The company depends on reimbursement from Medicare (for chronic care) for a significant portion of its revenues on account of the age demographics of its patient base (average age of 81).
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $19.704B 11.92
Quest Diagnostics (DGX) United States $16.912B 17.14
DaVita (DVA) United States $12.098B 15.65
Encompass Health (EHC) United States $9.453B 22.29
Chemed (CHE) United States $7.853B 24.14
Elanco Animal Health (ELAN) United States $5.843B 13.91
RadNet (RDNT) United States $5.284B 117.02
Option Care Health (OPCH) United States $3.848B 18.23
LifeStance Health (LFST) United States $2.698B 0.00
Addus HomeCare (ADUS) United States $2.350B 27.57
Astrana Health (ASTH) United States $1.974B 26.99
U.S Physical Therapy (USPH) United States $1.380B 36.27
Pennant (PNTG) United States $0.938B 37.92
Aveanna Healthcare Holdings (AVAH) United States $0.873B 0.00
Atai Life Sciences (ATAI) Germany $0.200B 0.00
Bioqual (BIOQ) United States $0.059B 0.00
Daxor (DXR) United States $0.039B 0.00
Ontrak (OTRK) United States $0.006B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.005B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00